Patents-Review.com
ClassID:

111527 ⎘

C12N2770/32332 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Picornaviridae; Enterovirus Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:
#1
20250304999
2025-10-02

GENETICALLY MODIFIED ENTEROVIRUS VECTORS WITH ENHANCED GENOMIC STABILITY

 #2
20240252564
2024-08-01

MIR-375- AND MIR-1-REGULATED COXSACKIEVIRUS B3 HAS NO PANCREAS AND HEART TOXICITY BUT STRONG ANTITUMOR EFFICIENCY IN COLORECTAL CARCINOMAS

 #3
20240115636
2024-04-11

ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE

 #4
20220267799
2022-08-25

GENETICALLY MODIFIED ENTEROVIRUS VECTORS

 #5
20220088098
2022-03-24

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

 #6
20220088097
2022-03-24

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

 #7
20210205384
2021-07-08

ECHO-7 ONCOLYTIC VIRUS FOR USE IN THE TREARMENT OF UVEAL MELANOMA

 #8
20210130414
2021-05-06

TREATING CANCER WITH VIRAL NUCLEIC ACID

 #9
20200297788
2020-09-24

COMBINATION METHOD FOR TREATMENT OF CANCER

 #10
20200254036
2020-08-13

Virus for treatment of tumor

 #11
20200023023
2020-01-23

Oncolytic virus growth method and antitumor agent

 #12
20190284538
2019-09-19

RECOMBINANT ONCOLYTIC VIRUS, SYNTHETIC DNA SEQUENCE, AND APPLICATION THEREOF

 #13
20190144833
2019-05-16

Genetically stable oncolytic RNA virus, method of manufacturing and use thereof

 #14
20190134120
2019-05-09

METHODS FOR THE TREATMENT OF BLADDER CANCER

 #15
20190134119
2019-05-09

Combination method for treatment of cancer

 #16
20190105360
2019-04-11

Sequential anti-cancer treatment

 #17
20190099460
2019-04-04

Method for treating cancer with a Coxsackievirus B3 (CVB3) variant

 #18
20180215794
2018-08-02

Treating cancer with viral nucleic acid

 #19
20180085411
2018-03-29

Optimized oncolytic viruses and uses thereof

 #20
20170348366
2017-12-07

METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME

 #21
20160376562
2016-12-29

Genetically stable oncolytic RNA virus, method of manufacturing and use thereof

 #22
20160250268
2016-09-01

METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME

 #23
20160143969
2016-05-26

Gene-modified coxsackievirus

 #24
20150299271
2015-10-22

Treating cancer with viral nucleic acid

 #25
20150273002
2015-10-01

METHODS AND COMPOSITIONS FOR TREATMENT OF HEMATOLOGIC CANCERS

 #26
20120328575
2012-12-27

Modified Oncolytic Viruses

 #27
20120064113
2012-03-15

Attenuated poliovirus

 #28
20110002943
2011-01-06

USE OF ENTEROVIRUS FOR DIAGNOSTICS, TREATMENT AND PREVENTION OF DISEASE

 #29
20100111873
2010-05-06

TREATING CANCER WITH VIRAL NUCLEIC ACID

 #30
20100104578
2010-04-29

METHOD AND COMPOSITION FOR TREATMENT OF NEOPLASMS

 #31
20100062020
2010-03-11

Method of Treating a Malignancy in a Subject Via Direct Picornaviral-Mediated Oncolysis

 #32
20100034848
2010-02-11

Prevention of allergic sensitization

 #33
20090246216
2009-10-01

Attenuated poliovirus

 #34
20090123427
2009-05-14

Methods for treating malignancies using coxsackieviruses

 #35
20080193479
2008-08-14

Methods and compositions for treatment of hematologic cancers

 #36
20080160031
2008-07-03

Method and Composition for Treatment of Neoplasms

 #37
20080057036
2008-03-06

Modified oncolytic viruses

 #38
20060134778
2006-06-22

Method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis